SWISS RE AG (SR9.DE) Fundamental Analysis & Valuation

FRA:SR9 • CH0126881561

142.75 EUR
+0.9 (+0.63%)
Last: Mar 4, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This SR9.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Overall SR9 gets a fundamental rating of 4 out of 10. We evaluated SR9 against 46 industry peers in the Insurance industry. SR9 has a medium profitability rating, but doesn't score so well on its financial health evaluation. SR9 is not valued too expensively and it also shows a decent growth rate. SR9 also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. SR9.DE Profitability Analysis

1.1 Basic Checks

  • SR9 had positive earnings in the past year.
  • In the past year SR9 had a positive cash flow from operations.
  • Of the past 5 years SR9 4 years were profitable.
  • In the past 5 years SR9 always reported a positive cash flow from operatings.
SR9.DE Yearly Net Income VS EBIT VS OCF VS FCFSR9.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

1.2 Ratios

  • With a decent Return On Assets value of 2.75%, SR9 is doing good in the industry, outperforming 76.09% of the companies in the same industry.
  • With a Return On Equity value of 15.53%, SR9 perfoms like the industry average, outperforming 56.52% of the companies in the same industry.
  • SR9 has a better Return On Invested Capital (2.77%) than 73.91% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for SR9 is in line with the industry average of 3.09%.
  • The last Return On Invested Capital (2.77%) for SR9 is above the 3 year average (2.05%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.75%
ROE 15.53%
ROIC 2.77%
ROA(3y)1.68%
ROA(5y)1.07%
ROE(3y)10.37%
ROE(5y)6.8%
ROIC(3y)2.05%
ROIC(5y)N/A
SR9.DE Yearly ROA, ROE, ROICSR9.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

  • SR9's Profit Margin of 8.36% is in line compared to the rest of the industry. SR9 outperforms 41.30% of its industry peers.
  • SR9's Profit Margin has improved in the last couple of years.
  • SR9 has a Operating Margin of 10.51%. This is in the lower half of the industry: SR9 underperforms 60.87% of its industry peers.
  • In the last couple of years the Operating Margin of SR9 has grown nicely.
Industry RankSector Rank
OM 10.51%
PM (TTM) 8.36%
GM N/A
OM growth 3Y38.28%
OM growth 5Y36.47%
PM growth 3Y31%
PM growth 5Y36.36%
GM growth 3YN/A
GM growth 5YN/A
SR9.DE Yearly Profit, Operating, Gross MarginsSR9.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. SR9.DE Health Analysis

2.1 Basic Checks

  • SR9 has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, SR9 has more shares outstanding
  • SR9 has a better debt/assets ratio than last year.
SR9.DE Yearly Shares OutstandingSR9.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
SR9.DE Yearly Total Debt VS Total AssetsSR9.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

2.2 Solvency

  • SR9 has a debt to FCF ratio of 2.64. This is a good value and a sign of high solvency as SR9 would need 2.64 years to pay back of all of its debts.
  • The Debt to FCF ratio of SR9 (2.64) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.35 indicates that SR9 is not too dependend on debt financing.
  • SR9's Debt to Equity ratio of 0.35 is fine compared to the rest of the industry. SR9 outperforms 76.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 2.64
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
SR9.DE Yearly LT Debt VS Equity VS FCFSR9.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SR9.DE Yearly Current Assets VS Current LiabilitesSR9.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. SR9.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 88.86% over the past year.
  • The Earnings Per Share has been growing by 33.96% on average over the past years. This is a very strong growth
  • SR9 shows a small growth in Revenue. In the last year, the Revenue has grown by 4.74%.
  • The Revenue has been decreasing by -1.49% on average over the past years.
EPS 1Y (TTM)88.86%
EPS 3Y31.5%
EPS 5Y33.96%
EPS Q2Q%1097.92%
Revenue 1Y (TTM)4.74%
Revenue growth 3Y-0.54%
Revenue growth 5Y-1.49%
Sales Q2Q%-1.6%

3.2 Future

  • SR9 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.82% yearly.
  • SR9 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.53% yearly.
EPS Next Y64.55%
EPS Next 2Y26.57%
EPS Next 3Y18.1%
EPS Next 5Y7.82%
Revenue Next Year-3.16%
Revenue Next 2Y-1.56%
Revenue Next 3Y-0.21%
Revenue Next 5Y2.53%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SR9.DE Yearly Revenue VS EstimatesSR9.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B
SR9.DE Yearly EPS VS EstimatesSR9.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

6

4. SR9.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 9.52 indicates a reasonable valuation of SR9.
  • 86.96% of the companies in the same industry are more expensive than SR9, based on the Price/Earnings ratio.
  • SR9's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.74.
  • Based on the Price/Forward Earnings ratio of 10.07, the valuation of SR9 can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, SR9 is valued a bit cheaper than the industry average as 63.04% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 24.82. SR9 is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.52
Fwd PE 10.07
SR9.DE Price Earnings VS Forward Price EarningsSR9.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • SR9's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 13.72
EV/EBITDA N/A
SR9.DE Per share dataSR9.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • SR9's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • SR9's earnings are expected to grow with 18.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.15
PEG (5Y)0.28
EPS Next 2Y26.57%
EPS Next 3Y18.1%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. SR9.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.58%, SR9 is a good candidate for dividend investing.
  • SR9's Dividend Yield is a higher than the industry average which is at 4.03.
  • SR9's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.58%

5.2 History

  • The dividend of SR9 has a limited annual growth rate of 3.80%.
Dividend Growth(5Y)3.8%
Div Incr Years0
Div Non Decr Years0
SR9.DE Yearly Dividends per shareSR9.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 1 2 3 4 5

5.3 Sustainability

  • SR9 pays out 58.32% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • SR9's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP58.32%
EPS Next 2Y26.57%
EPS Next 3Y18.1%
SR9.DE Yearly Income VS Free CF VS DividendSR9.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B
SR9.DE Dividend Payout.SR9.DE Dividend Payout, showing the Payout Ratio.SR9.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SR9.DE Fundamentals: All Metrics, Ratios and Statistics

SWISS RE AG

FRA:SR9 (3/4/2026, 7:00:00 PM)

142.75

+0.9 (+0.63%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-27
Earnings (Next)05-07
Inst Owners39.19%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap42.65B
Revenue(TTM)45.26B
Net Income(TTM)3.72B
Analysts51.43
Price Target146.21 (2.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.58%
Yearly Dividend5.73
Dividend Growth(5Y)3.8%
DP58.32%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.09%
Min EPS beat(2)-11.28%
Max EPS beat(2)25.45%
EPS beat(4)2
Avg EPS beat(4)-17.07%
Min EPS beat(4)-85.46%
Max EPS beat(4)25.45%
EPS beat(8)4
Avg EPS beat(8)-6.39%
EPS beat(12)5
Avg EPS beat(12)-30.28%
EPS beat(16)6
Avg EPS beat(16)-37.64%
Revenue beat(2)0
Avg Revenue beat(2)-9.19%
Min Revenue beat(2)-13.74%
Max Revenue beat(2)-4.65%
Revenue beat(4)0
Avg Revenue beat(4)-6.85%
Min Revenue beat(4)-13.74%
Max Revenue beat(4)-1.11%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-11.6%
PT rev (3m)-11.6%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)0.79%
Valuation
Industry RankSector Rank
PE 9.52
Fwd PE 10.07
P/S 1.12
P/FCF 13.72
P/OCF 13.72
P/B 2.08
P/tB 2.5
EV/EBITDA N/A
EPS(TTM)15
EY10.51%
EPS(NY)14.18
Fwd EY9.93%
FCF(TTM)10.41
FCFY7.29%
OCF(TTM)10.41
OCFY7.29%
SpS127.73
BVpS68.74
TBVpS57.14
PEG (NY)0.15
PEG (5Y)0.28
Graham Number152.32
Profitability
Industry RankSector Rank
ROA 2.75%
ROE 15.53%
ROCE 3.5%
ROIC 2.77%
ROICexc 2.85%
ROICexgc 3.26%
OM 10.51%
PM (TTM) 8.36%
GM N/A
FCFM 8.15%
ROA(3y)1.68%
ROA(5y)1.07%
ROE(3y)10.37%
ROE(5y)6.8%
ROIC(3y)2.05%
ROIC(5y)N/A
ROICexc(3y)2.12%
ROICexc(5y)N/A
ROICexgc(3y)2.47%
ROICexgc(5y)N/A
ROCE(3y)2.58%
ROCE(5y)N/A
ROICexgc growth 3Y50.76%
ROICexgc growth 5Y52.33%
ROICexc growth 3Y53.43%
ROICexc growth 5Y51.85%
OM growth 3Y38.28%
OM growth 5Y36.47%
PM growth 3Y31%
PM growth 5Y36.36%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 2.64
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 8.77
Cash Conversion N/A
Profit Quality 97.47%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)285.69%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.86%
EPS 3Y31.5%
EPS 5Y33.96%
EPS Q2Q%1097.92%
EPS Next Y64.55%
EPS Next 2Y26.57%
EPS Next 3Y18.1%
EPS Next 5Y7.82%
Revenue 1Y (TTM)4.74%
Revenue growth 3Y-0.54%
Revenue growth 5Y-1.49%
Sales Q2Q%-1.6%
Revenue Next Year-3.16%
Revenue Next 2Y-1.56%
Revenue Next 3Y-0.21%
Revenue Next 5Y2.53%
EBIT growth 1Y3.78%
EBIT growth 3Y37.53%
EBIT growth 5Y34.43%
EBIT Next Year47.56%
EBIT Next 3Y11.45%
EBIT Next 5YN/A
FCF growth 1Y50.35%
FCF growth 3Y-8.64%
FCF growth 5Y13.41%
OCF growth 1Y50.35%
OCF growth 3Y-8.64%
OCF growth 5Y13.41%

SWISS RE AG / SR9.DE FAQ

What is the ChartMill fundamental rating of SWISS RE AG (SR9.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to SR9.DE.


What is the valuation status of SWISS RE AG (SR9.DE) stock?

ChartMill assigns a valuation rating of 6 / 10 to SWISS RE AG (SR9.DE). This can be considered as Fairly Valued.


How profitable is SWISS RE AG (SR9.DE) stock?

SWISS RE AG (SR9.DE) has a profitability rating of 5 / 10.


Can you provide the financial health for SR9 stock?

The financial health rating of SWISS RE AG (SR9.DE) is 2 / 10.


Can you provide the expected EPS growth for SR9 stock?

The Earnings per Share (EPS) of SWISS RE AG (SR9.DE) is expected to grow by 64.55% in the next year.